Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun;153(6):1387-1395.
doi: 10.1016/j.chest.2018.01.006. Epub 2018 Jan 17.

Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease

Affiliations

Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease

Whitney D Gannon et al. Chest. 2018 Jun.

Abstract

Background: We aimed to examine short- and long-term mortality in a mixed population of patients with interstitial lung disease (ILD) with acute respiratory failure, and to identify those at lower vs higher risk of in-hospital death.

Methods: We conducted a single-center retrospective cohort study of 126 consecutive adults with ILD admitted to an ICU for respiratory failure at a tertiary care hospital between 2010 and 2014 and who did not undergo lung transplantation during their hospitalization. We examined associations of ICU-day 1 characteristics with in-hospital and 1-year mortality, using Poisson regression, and examined survival using Kaplan-Meier curves. We created a risk score for in-hospital mortality, using a model developed with penalized regression.

Results: In-hospital mortality was 66%, and 1-year mortality was 80%. Those with connective tissue disease-related ILD had better short-term and long-term mortality compared with unclassifiable ILD (adjusted relative risk, 0.6; 95% CI, 0.3-0.9; and relative risk, 0.6; 95% CI, 0.4-0.9, respectively). Our prediction model includes male sex, interstitial pulmonary fibrosis diagnosis, use of invasive mechanical ventilation and/or extracorporeal life support, no ambulation within 24 h of ICU admission, BMI, and Simplified Acute Physiology Score-II. The optimism-corrected C-statistic was 0.73, and model calibration was excellent (P = .99). In-hospital mortality rates for the low-, moderate-, and high-risk groups were 33%, 65%, and 96%, respectively.

Conclusions: We created a risk score that classifies patients with ILD with acute respiratory failure from low to high risk for in-hospital mortality. The score could aid providers in counseling these patients and their families.

Keywords: idiopathic interstitial pneumonia; idiopathic pulmonary fibrosis; intensive care; interstitial lung disease; respiratory failure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier 1-year survival curves from the time of hospitalization for acute respiratory failure for categories of interstitial lung disease. CTD-ILD = connective tissue disease-related ILD; ILD = interstitial lung disease; IPF = idiopathic pulmonary fibrosis; uILD = unclassifiable ILD. P value is for the log-rank test.
Figure 2
Figure 2
A, Frequency distribution of patients by predicted risk of in-hospital mortality based on the low-, moderate-, and high-risk score. B, Kaplan-Meier 1-year survival curves from the time of hospitalization for acute respiratory failure by low-, medium-, and high-risk categories. P value is for the log-rank test.

References

    1. Rosas I.O., Dellaripa P.F., Lederer D.J., Khanna D., Young L.R., Martinez F.J. Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc. 2014;11(suppl 3):S169–S177. - PMC - PubMed
    1. Raghu G., Chen S.Y., Yeh W.S. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. Lancet Respir Med. 2014;2(7):566–572. - PubMed
    1. Bouros D., Wells A.U., Nicholson A.G. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med. 2002;165(12):1581–1586. - PubMed
    1. Fischer A., Swigris J.J., Groshong S.D. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival. Chest. 2008;134(3):601–605. - PubMed
    1. Lee H.K., Kim D.S., Yoo B. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005;127(6):2019–2027. - PubMed

Publication types